ArriVent BioPharma, Inc. Common Stock
AVBP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$35 | -$31 | -$64 | -$21 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $4 | $3 | $2 | $1 |
| Change in WC | -$5 | $2 | -$6 | $4 |
| Other Non-Cash | $0 | $0 | $0 | $0 |
| Operating Cash Flow | -$36 | -$26 | -$68 | -$16 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$90 | -$22 | -$10 | -$194 |
| Inv. Sales/Matur. | $40 | $35 | $47 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $2 |
| Investing Cash Flow | -$51 | $14 | $37 | -$192 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $86 | $75 | $7 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$0 | $0 | $0 |
| Financing Cash Flow | $86 | $75 | $7 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$0 | $63 | -$24 | -$209 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $113 | $50 | $74 | $283 |
| End Cash | $113 | $113 | $50 | $74 |
| Free Cash Flow | -$36 | -$26 | -$68 | -$16 |